Home Categories Send inquiry

PMDT-9000 Immunofluorescence Analyzer (Single channel)

Product description

Intended Use: PMDT 9000 Immunofluorescence Quantitative Analyzer is an analyzer for processing and analysis of PMDT test kits including markers for cardiovascular diseases, renal diseases, inflammation, fertility, diabetes mellitus, bone metabolism, tumor, and thyroid, etc. PMDT 9000 is used to measure concentration of biomarkers in human whole blood, serum, plasma or urine samples. The results can be used as an aid in clinical diagnosis of laboratory and point of care testing. It is applicable in Emergency, Clinical Lab, Outpatient, ICU, CCU, Cardiology, ambulance, operating room, wards, etc.

better designed POCT

★ steady structure for reliable results ★ auto alert to clean polluted cassettes ★ 9’screen, manipulation friendly ★ various ways of data exporting ★ full IP of testing system and kits ★ high-precision testing parts ★ independent testing tunnels ★ temperature & humidity auto-control ★ auto QC and self-checking ★ reacting time auto-control ★ auto-saving data

more accurate POCT

more intelligent POCT

★ high-throughput for gargantuan testing needs ★ testing cassettes auto-reading ★ various testing samples available ★ fitting in many emergency situations ★ capable to connect printer directly (special model only) ★ registered QC for all testing kits ★ registered QC for all testing kits ★ real-time monitoring of every tunnels ★ touch-screen instead of mouse and keyboard ★ AI chip for data management

Steps for usage


Cardiology / Hematology / Nephrology / Gastroenterology /Respiratory Anti-coagulation and Anti-thrombotic management in patients with coronary heart disease, myocardial infarction and cerebral infarction. Bleeding and coagulation monitoring in in patients with hemophilia, dialysis, renal failure, liver cirrhosis and gastrointestinal bleeding Orthopedics / Neurosurgery / General surgery / Alcohol / Transplantation / Oncology Coagulation monitoring in pre-, intra- and post-operation management Evaluation of heparin neutralization Guide the Component Transfusion Improve the blood coagulation detection methods Identify the high-risk thrombosis / bleeding cases Cardiology Department / Neurology Department / Vascular Surgery Department Monitoring of Interventional therapy, thrombolytic therapy Monitoring of individualized antiplatelet therapy

Diagnostic items list

Category Product name Full name Clinical solutions
Cardiac sST2/NT-proBNP Soluble ST2/ N-Terminal Pro-Brain Natriuretic Peptide Clinical diagnosis of heart failure
cTnl cardiac troponin I Highly sensitive and specific marker of myocardial damage
NT-proBNP N-Terminal Pro-Brain Natriuretic Peptide Clinical diagnosis of heart failure
BNP brainnatriureticpeptide Clinical diagnosis of heart failure
Lp-PLA2 lipoprotein associated phospholipase A2 Marker of vascular inflammation and atherosclerosis
S100-β S100-β protein Marker of blood–brain barrier (BBB) permeability and central nervous system(CNS) injury
CK-MB/cTnl creatine kinase-MB/cardiac troponin I Highly sensitive and specific marker of myocardial damage
CK-MB creatine kinase-MB Highly sensitive and specific marker of myocardial damage
Myo Myoglobin Sensitive marker for heart or muscle injury
ST2 soluble growth stimulation expressed gene 2 Clinical diagnosis of heart failure
CK-MB/cTnI/Myo - Highly sensitive and specific marker of myocardial damage
H-fabp Heart-type fatty acid-binding protein Clinical diagnosis of heart failure
Coagulation D-Dimer D-dimer Diagnosis of coagulation
Inflammation CRP C-reactive protein Evaluation of inflammation
SAA serum amyloid A protein Evaluation of inflammation
hs-CRP+CRP The high-sensitivity C-reactive protein +C-reactive protein Evaluation of inflammation
SAA/CRP - Virus infection
PCT procalcitonin Identification and diasnosis of bacterial infection,guiding the application of antibiotics
IL-6 Interleukin- 6 Identification and diasnosis of inflammation and infection
Renal Function MAU Microalbumininurine Risk evaluation of kidney disease
NGAL neutrophil gelatinase associated lipocalin Marker of acute renal injury
Diabetes HbA1c Hemoglobin A1C The best indicator to monitior the control of blood glucose of the diabetics
Health N-MID N-MID OsteocalcinFIA Monitoring therapeutic treatments of Osteoporosis
Ferritin Ferritin Prediction of Iron deficiency anemia
25-OH-VD 25-Hydroxy Vitamin D indicator of osteoporosis (bone weakness) and rickets (bone malformation)
VB12 vitamin B12 Symptoms of vitamin B12 deficiency
Thyroid TSH thyroid stimulating hormone Indicator for the diagnosis and treatment of hyperthyroidism and hypothyroidism and the study of the hypothalamic-pituitary-thyroid axis
T3 Triiodothyronine indicators for the diagnosis of hyperthyroidism
T4 Thyroxine indicators for the diagnosis of hyperthyroidism
Hormone FSH follicle-stimulating hormone Assist in assessing ovarian health
LH luteinizing hormone Assist in determining pregnancy
PRL Prolactin For pituitary microtumor, reproductive biology study
Cortisol Human Cortisol Adrenal cortical function diagnosis
FA folic acid Prevention of fetal neural tube malformation, pregnant women/newborn nutrition judgment
β-HCG β-human chorionic gonadotropin Assist in determining pregnancy
T Testosterone Assist to evaluate the endocrine hormone situation
Prog progesterone Diagnosis of pregnancy
AMH anti-mullerian hormone Evaluation the fertility
INHB Inhibin B Marker of remaining fertility and ovarian function
E2 Estradiol The main sex hormones for women
Gastric PGI/II Pepsinogen I, Pepsinogen II Diagnosis of gastric mucosa injury
G17 Gastrin 17 Gastric acid secretion, gastric health indicators
Cancer PSA Assist in the diagnosis of prostate cancer
AFP alPhafetoProtein Marker of liver cancer serum
CEA carcinoembryonic antigen Assist in the diagnosis of colorectal cancer, pancreatic cancer, gastric cancer, breast cancer, medullary thyroid cancer, liver cancer, lung cancer, ovarian cancer, urinary system tumors

About Immunofluorescence

Immunofluorescence is a type of assay performed on biological samples to detect specific antigens in any biological specimen or sample and vice-versa. It was described in 1942 and refined by Coons in 1950, which used a fluorescence microscope able to read the specific immunological reaction and cellular slide preparations.

Principle of Immunofluorescence

Specific antibodies bind to the protein or antigen of interest. Antibodies could be labeled with molecules that have the property of fluorescence (fluorochromes) When light of one wavelength falls on fluorochrome, it absorbs that light to emit light of another wavelength. The emitted light can be viewed with a fluorescence analyzer

PMDT-9000 Immunofluorescence Analyzer (Single channel) Related Video: